Article

Two retired executives join B&L board

Bausch & Lomb announced the addition of two members to its board of directors, J. Raymond Elliott and Richard F. Wallman.

Rochester NY-Bausch & Lomb (B&L) announced the addition of two members to its board of directors, J. Raymond Elliott and Richard F. Wallman.

From 2001 until his retirement in 2007, Elliott served as chairmen, president, and chief executive of orthopedic instrument manufacturer Zimmer Holdings Inc. Wallman was senior vice president and chief financial officer of aerospace equipment manufacturer Honeywell International Inc. from 1995 until his retirement in 2003.

For almost 30 years Elliott held general management positions in the health care, media, and consumer products industries. He also recently joined the board of Boston Scientific Corp.

Before his time at Honeywell, Wallman was vice president and controller at IBM Corp. and held leadership positions at Chrysler Corp.

These two executives join newly appointed board chairman Gerald Ostrov, chief executive officer Joseph P. Landy, Elizabeth H. Weatherman, and Sean D. Carney, all managing directors of Warburg Pincus LLC, and D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.